MetLife Investment Advisors LLC raised its stake in HB Fuller Co (NYSE:FUL) by 5.5% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,194 shares of the specialty chemicals company’s stock after acquiring an additional 1,200 shares during the quarter. MetLife Investment Advisors LLC’s holdings in HB Fuller were worth $1,245,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. BlackRock Inc. increased its position in HB Fuller by 6.1% in the 2nd quarter. BlackRock Inc. now owns 7,233,376 shares of the specialty chemicals company’s stock valued at $388,286,000 after acquiring an additional 415,166 shares in the last quarter. Janus Henderson Group PLC increased its position in HB Fuller by 13.5% in the 2nd quarter. Janus Henderson Group PLC now owns 2,809,497 shares of the specialty chemicals company’s stock valued at $150,814,000 after acquiring an additional 335,020 shares in the last quarter. Champlain Investment Partners LLC increased its position in HB Fuller by 6.0% in the 1st quarter. Champlain Investment Partners LLC now owns 1,896,135 shares of the specialty chemicals company’s stock valued at $94,295,000 after acquiring an additional 108,115 shares in the last quarter. Cooke & Bieler LP increased its position in HB Fuller by 11.1% in the 2nd quarter. Cooke & Bieler LP now owns 459,310 shares of the specialty chemicals company’s stock valued at $24,656,000 after acquiring an additional 45,730 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. increased its position in HB Fuller by 9.3% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 398,043 shares of the specialty chemicals company’s stock valued at $21,367,000 after acquiring an additional 33,956 shares in the last quarter. Hedge funds and other institutional investors own 97.65% of the company’s stock.

FUL has been the subject of several research reports. Zacks Investment Research cut shares of HB Fuller from a “buy” rating to a “hold” rating in a research report on Monday, September 3rd. Berenberg Bank began coverage on shares of HB Fuller in a research report on Thursday, July 12th. They set a “buy” rating and a $65.00 price target for the company. Finally, JPMorgan Chase & Co. reiterated an “overweight” rating and set a $57.00 price target on shares of HB Fuller in a research report on Thursday, July 5th. Four analysts have rated the stock with a hold rating and five have issued a buy rating to the company. HB Fuller presently has an average rating of “Buy” and an average target price of $61.13.

Shares of NYSE:FUL opened at $57.23 on Wednesday. HB Fuller Co has a one year low of $46.62 and a one year high of $59.58. The company has a quick ratio of 1.46, a current ratio of 2.24 and a debt-to-equity ratio of 2.07. The company has a market cap of $2.95 billion, a PE ratio of 22.89, a price-to-earnings-growth ratio of 0.95 and a beta of 1.48.

HB Fuller (NYSE:FUL) last issued its quarterly earnings results on Wednesday, June 27th. The specialty chemicals company reported $0.89 EPS for the quarter, topping the consensus estimate of $0.86 by $0.03. HB Fuller had a net margin of 4.00% and a return on equity of 12.66%. The company had revenue of $789.39 million during the quarter, compared to analysts’ expectations of $808.06 million. equities research analysts forecast that HB Fuller Co will post 3.23 earnings per share for the current fiscal year.

In related news, VP Steven Kenny sold 2,200 shares of the business’s stock in a transaction that occurred on Monday, July 30th. The shares were sold at an average price of $56.19, for a total transaction of $123,618.00. Following the completion of the transaction, the vice president now owns 30,173 shares in the company, valued at $1,695,420.87. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Sant R. William Van sold 5,500 shares of the business’s stock in a transaction that occurred on Friday, June 29th. The shares were sold at an average price of $54.12, for a total transaction of $297,660.00. Following the transaction, the director now owns 17,665 shares of the company’s stock, valued at approximately $956,029.80. The disclosure for this sale can be found here. In the last quarter, insiders have sold 12,208 shares of company stock valued at $680,263. 3.46% of the stock is owned by corporate insiders.

HB Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, and other specialty chemical products worldwide. The company operates through six segments: Americas Adhesives; EIMEA (Europe, India, Middle East and Africa); Asia Pacific; Construction Products; Engineering Adhesives; and Royal Adhesives.

Read More: Market Capitalization

Want to see what other hedge funds are holding FUL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HB Fuller Co (NYSE:FUL).

Institutional Ownership by Quarter for HB Fuller (NYSE:FUL)

Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.